FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2911970 · Received January 11, 2013

Report

Report Number
2124215-2012-16395
Event Type
Malfunction
Date Received
January 11, 2013
Date of Event
December 2, 2012
Report Date
February 1, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P010012
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION INDICATES THAT THE PATIENT WILL CONTINUED TO BE FOLLOWED AT THIS TIME. NO SURGICAL INTERVENTION HAS BEEN PLANNED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXHIBITED HIGH OUT OF RANGE SHOCK IMPEDANCES. NO ADVERSE PATIENT EFFECTS WERE REPORTED. AT THIS TIME, NO FURTHER INFORMATION HAS BEEN MADE AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
17084 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 32 YR 0137| E102